Prevalence of Frailty and Associated Factors in Coronary Artery Bypass Patients

March 26, 2024 updated by: Uşak University

This study aimed to determine the prevalence of and factors affecting frailty in patients with coronary artery bypass graft.

The main question it aims to answer are:

What are the prevalence of and factors affecting frailty in patients with coronary artery bypass graft Type of study: descriptive cross-sectional study Participant population: coronary artery bypass grafting patients

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

96

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Center
      • Usak, Center, Turkey, 64200
        • Uşak University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

coronary artery bypass grafting patients

Description

Inclusion Criteria:

  • 18 years and older
  • planned CABG surgery
  • volunteer to participate in the study

Exclusion Criteria:

  • limb amputations
  • stroke-related sequela
  • hearing problems
  • clinically unstable

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of frailty
Time Frame: Preoperative
Modified Fried Frailty Index
Preoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Activities of Daily Living
Time Frame: Preoperative
Barthel Activities of Daily Living Index
Preoperative
Nutritional Assessment
Time Frame: Preoperative
Mini Nutritional Assessment Test-Short Form
Preoperative
Comorbidity
Time Frame: Preoperative
Charlson Comorbidity Index
Preoperative
Cognitive Assessment
Time Frame: Preoperative
Montreal Cognitive Assessment
Preoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Uşak University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 18, 2021

Primary Completion (Actual)

February 18, 2022

Study Completion (Actual)

February 18, 2022

Study Registration Dates

First Submitted

March 26, 2024

First Submitted That Met QC Criteria

March 26, 2024

First Posted (Actual)

April 2, 2024

Study Record Updates

Last Update Posted (Actual)

April 2, 2024

Last Update Submitted That Met QC Criteria

March 26, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • FRAILTY

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Frailty

Clinical Trials on prevalence of frailty

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Czech Republic

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe